Improve Your Sleep

Sleep medications

click the DOI links to access the publications

  • Zee, P. C., Bertisch, S. M., Morin, C. M., Pelayo, R., Watson, N. F., Winkelman, J. W., & Krystal, A. D. (2023). Long-Term Use of Insomnia Medications: An Appraisal of the Current Clinical and Scientific Evidence. Journal of Clinical Medicine, 12(4), 1629-.

    DOI: https://doi.org/10.3390/jcm12041629

  • Edinger, J. D., Wamboldt, F. S., Johnson, R. L., Simmons, B., Tsai, S., Morin, C. M., & Holm, K. E. (2023). Adherence to behavioral recommendations of cognitive behavioral therapy for insomnia predicts medication use after a structured medication taper. Journal of Clinical Sleep Medicine, 19(8), 1495-1503.

    DOI: https://doi.org/10.5664/jcsm.10616

  • Morin, C. M., Chen, S.-J., Ivers, H., Beaulieu-Bonneau, S., Krystal, A. D., Guay, B., Bélanger, L., Cartwright, A., Simmons, B., Lamy, M., Busby, M., & Edinger, J. D. (2023). Effect of Psychological and Medication Therapies for Insomnia on Daytime Functions: A Randomized Clinical Trial. JAMA Network Open, 6(12), e2349638–e2349638. 

    DOI: https://doi.org/10.1001/jamanetworkopen.2023.49638

  • Patel, J., Ali, N., Corkum, P., & Weiss, S. (2024). Insomnia in children with neurodevelopmental disorders: do parent or child factors affect the use of medications? Sleep Medicine, 115, 272–272.

    DOI: https://doi.org/10.1016/j.sleep.2023.11.745

  • Shenoy, P., Etcheverry, A., Ia, J., Witmans, M., & Tablizo, M. A. (2024). Melatonin Use in Pediatrics: A Clinical Review on Indications, Multisystem Effects, and Toxicity. Children (Basel), 11(3), 323-.

    DOI: https://doi.org/10.3390/children11030323

  • Glass, A., Attrill, C., Magee, C., & Blunden, S. (2023). Factors associated with melatonin use in child sleep disturbance: A survey of Australian parents. Sleep Medicine, 107, 330–337.

    DOI: https://doi.org/10.1016/j.sleep.2023.04.026

  • Kotagal, S., Malow, B., Spruyt, K., Wang, G., Bolaños Almeida, C. E., Tavera Saldaña, L. M., Blunden, S., Narang, I., Ipsiroglu, O. S., Bruni, O., Strazisar, B. G., Simakajornboon, N., Nunes, M. L., & Cortese, S. (2024). Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA). Sleep Medicine, 119, 222–228.

    DOI: https://doi.org/10.1016/j.sleep.2024.04.008

  • Lancee, J., Morin, C. M., Edinger, J. D., Ivers, H., van der Zweerde, T., & Blanken, T. F. (2023). Symptom-specific effects of zolpidem and behavioral treatment for insomnia: a network intervention analysis. Sleep (New York, N.Y.), 46(11), 1-.

    DOI: https://doi.org/10.1093/sleep/zsad240

  • Pelayo, R., Bertisch, S. M., Morin, C. M., Winkelman, J. W., Zee, P. C., & Krystal, A. D. (2023). Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal. Journal of Clinical Medicine, 12(8), 2933-.

    DOI: https://doi.org/10.3390/jcm12082933

  •  Roth, T., Rosenberg, R., Morin, C. M., Yardley, J., Pinner, K., Perdomo, C., Atkins, N., Pappadopulos, E., Malhotra, M., & Moline, M. (2022). Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder. Sleep Medicine, 90, 249–257.

    DOI: https://doi.org/10.1016/j.sleep.2022.01.024